At close: January 6 at 4:00:01 PM EST
After hours: January 6 at 4:01:21 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-166,184.00
-192,231.00
-5,853.00
-124,982.00
-67,881.00
Investing Cash Flow
31,468.00
68,355.00
-225,644.00
15,461.00
58,289.00
Financing Cash Flow
2,370.00
115,068.00
219,382.00
2,476.00
214,781.00
End Cash Position
43,065.00
113,112.00
121,920.00
134,035.00
241,080.00
Income Tax Paid Supplemental Data
--
625.00
--
--
--
Capital Expenditure
-6,438.00
-12,381.00
-10,206.00
-13,244.00
-17,502.00
Issuance of Capital Stock
--
113,564.00
217,987.00
--
215,691.00
Free Cash Flow
-172,622.00
-204,612.00
-16,059.00
-138,226.00
-85,383.00
12/31/2020 - 9/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCYC Bicycle Therapeutics plc
14.88
-0.07%
ALXO ALX Oncology Holdings Inc.
1.7900
-1.10%
YMAB Y-mAbs Therapeutics, Inc.
7.81
-4.41%
ORIC ORIC Pharmaceuticals, Inc.
8.32
-2.69%
ALEC Alector, Inc.
2.0200
-1.94%
RVMD Revolution Medicines, Inc.
43.84
-0.63%
COGT Cogent Biosciences, Inc.
8.06
+2.28%
IDYA IDEAYA Biosciences, Inc.
25.69
-1.19%
DNLI Denali Therapeutics Inc.
19.82
-6.77%
REPL Replimune Group, Inc.
12.02
-4.75%